[
  {
    "ts": null,
    "headline": "Johnson & Johnson stock outperforms competitors despite losses on the day",
    "summary": "Johnson & Johnson stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=27931eb3e4a59cdf5aeaee3878f2fb74965ebb99f99764eb4c3e4163c841511f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733243460,
      "headline": "Johnson & Johnson stock outperforms competitors despite losses on the day",
      "id": 131775378,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=27931eb3e4a59cdf5aeaee3878f2fb74965ebb99f99764eb4c3e4163c841511f"
    }
  },
  {
    "ts": null,
    "headline": "MeiraGTx Holdings: Behind The Recent Rally",
    "summary": "MeiraGTx Holdings plc sees a surge in stock after positive Parkinson's disease data and strategic partnerships, showing growth potential. Click for my MGTX update.",
    "url": "https://finnhub.io/api/news?id=242d137a67b8f3fc6c2cc10c9328b3e988b07ce841ba6745239fdeee6c6425f2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733235534,
      "headline": "MeiraGTx Holdings: Behind The Recent Rally",
      "id": 131757226,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148853423/image_2148853423.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "MeiraGTx Holdings plc sees a surge in stock after positive Parkinson's disease data and strategic partnerships, showing growth potential. Click for my MGTX update.",
      "url": "https://finnhub.io/api/news?id=242d137a67b8f3fc6c2cc10c9328b3e988b07ce841ba6745239fdeee6c6425f2"
    }
  },
  {
    "ts": null,
    "headline": "You Buy Products From These Dual Dividend Aristocrat and Dividend King Stocks Every Day – Why Not Earn Passive Income On Their Shares?",
    "summary": "Have you ever looked high and low for something without realizing it was right in front of you the entire time? It's a surprisingly common situation, especially for passive income investors seeking reliable dividend stocks. You may consider investing ...",
    "url": "https://finnhub.io/api/news?id=ce7425ca8f2cd520c94c6ca94bdeee53ed86eb9fd9c44ef1ecca9cf3381a7895",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733234445,
      "headline": "You Buy Products From These Dual Dividend Aristocrat and Dividend King Stocks Every Day – Why Not Earn Passive Income On Their Shares?",
      "id": 131754579,
      "image": "https://media.zenfs.com/en/benzinga_79/d473e3c79ee0d10895a74d5ab7065874",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Have you ever looked high and low for something without realizing it was right in front of you the entire time? It's a surprisingly common situation, especially for passive income investors seeking reliable dividend stocks. You may consider investing ...",
      "url": "https://finnhub.io/api/news?id=ce7425ca8f2cd520c94c6ca94bdeee53ed86eb9fd9c44ef1ecca9cf3381a7895"
    }
  },
  {
    "ts": null,
    "headline": "J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids",
    "summary": "J&J files for FDA approval of Tremfya for plaque psoriasis and psoriatic arthritis indications in pediatric patients",
    "url": "https://finnhub.io/api/news?id=1caf7d3e3d9b33a4d129c81ae662da556772642b45d708b91de539b460e5229e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733234280,
      "headline": "J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids",
      "id": 131754580,
      "image": "https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J files for FDA approval of Tremfya for plaque psoriasis and psoriatic arthritis indications in pediatric patients",
      "url": "https://finnhub.io/api/news?id=1caf7d3e3d9b33a4d129c81ae662da556772642b45d708b91de539b460e5229e"
    }
  },
  {
    "ts": null,
    "headline": "37% Of This Johnson & Johnson Insider's Holdings Were Sold",
    "summary": "Viewing insider transactions for Johnson & Johnson's ( NYSE:JNJ ) over the last year, we see that insiders were net...",
    "url": "https://finnhub.io/api/news?id=61294c376edea1cd768feb0e2d68b87902b5ece99ff57e5aa7e6e4d41fe82215",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733227221,
      "headline": "37% Of This Johnson & Johnson Insider's Holdings Were Sold",
      "id": 131754582,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2eedc463aef15274c4887c130e30e298",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Viewing insider transactions for Johnson & Johnson's ( NYSE:JNJ ) over the last year, we see that insiders were net...",
      "url": "https://finnhub.io/api/news?id=61294c376edea1cd768feb0e2d68b87902b5ece99ff57e5aa7e6e4d41fe82215"
    }
  },
  {
    "ts": null,
    "headline": "J&J’s sBLAs seek FDA approval of TREMFYA for paediatric conditions",
    "summary": "The submission for treating paediatric plaque psoriasis is supported by outcomes from the Phase III PROTOSTAR study in children.",
    "url": "https://finnhub.io/api/news?id=ec5eb8320b52198521ca2adf835d9f8635f47076591e7cb7cdbf8fcc94567afe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733224798,
      "headline": "J&J’s sBLAs seek FDA approval of TREMFYA for paediatric conditions",
      "id": 131750521,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2024/12/Pharma-2-JJ-psoriasis-Shutterstock_2251746079.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The submission for treating paediatric plaque psoriasis is supported by outcomes from the Phase III PROTOSTAR study in children.",
      "url": "https://finnhub.io/api/news?id=ec5eb8320b52198521ca2adf835d9f8635f47076591e7cb7cdbf8fcc94567afe"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA",
    "summary": "SPRING HOUSE - Johnson & Johnson today announced the submission of two supplemental Biologics License Applications to the U.S. Food and Drug Administration seeking approval of TREMFYA for the...",
    "url": "https://finnhub.io/api/news?id=6706aee60a59570d9348ea9f05e41b1278803ba7f8aecae4783ddd5ecfd9e70f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733222255,
      "headline": "Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA",
      "id": 131753981,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "SPRING HOUSE - Johnson & Johnson today announced the submission of two supplemental Biologics License Applications to the U.S. Food and Drug Administration seeking approval of TREMFYA for the...",
      "url": "https://finnhub.io/api/news?id=6706aee60a59570d9348ea9f05e41b1278803ba7f8aecae4783ddd5ecfd9e70f"
    }
  },
  {
    "ts": null,
    "headline": "PBM Contracting And Administration: What Are The Rules Of The Road For Self-Insured Employees?",
    "summary": "In February 2024, a group representing the Johnson & Johnson Group Health Plan and its component plans sued Johnson & Johnson and The Pension & Benefits Committee of Johnson and Johnson over the...",
    "url": "https://finnhub.io/api/news?id=8274ca396a39129f15cf9202759774851510b29e5bc1c78eef9b69c71df0694e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733209810,
      "headline": "PBM Contracting And Administration: What Are The Rules Of The Road For Self-Insured Employees?",
      "id": 131750969,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "In February 2024, a group representing the Johnson & Johnson Group Health Plan and its component plans sued Johnson & Johnson and The Pension & Benefits Committee of Johnson and Johnson over the...",
      "url": "https://finnhub.io/api/news?id=8274ca396a39129f15cf9202759774851510b29e5bc1c78eef9b69c71df0694e"
    }
  }
]